EUVIMEDEUVIMED entdecken
Crossref

Long‐term control of diabetes by tofacitinib‐based immunosuppressive regimen after allo islet transplantation in diabetic rhesus monkeys that rejected previously transplanted porcine islets

Jong-Min Kim iD, Seong-Jun Kang iD, So-Hee Hong iD, Hyunwoo Chung iD, Jun-Seop Shin iD, Byoung-Hoon Min iD, Hyun Je Kim iD, Jongwon Ha iD, Chung-Gyu Park iD

Xenotransplantation · 2024

DOI: 10.1111/xen.12850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Xenotransplantation, 2024. Verfasst von Jong-Min Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Xenotransplantation Research Center, Seoul National University, College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Diabetes Mellitus, Islets of Langerhans, Piperidines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine islet xenotransplantation has been highlighted as an alternative to allo islet transplantation. Despite the remarkable progress that has been made in porcine‐islet pre‐clinical studies in nonhuman primates, immunological tolerance to porcine islets has not been achieved to date. Therefore, allo islet transplantation could be required after the failure of porcine islet xenotransplantation. Here, we report the long‐term control of diabetes by allogeneic pancreatic islet transplantation in diabetic rhesus monkeys that rejected previously transplanted porcine islets. Four diabetic male rhesus monkeys received the porcine islets and then allo islets (5700—19 000 IEQ/kg) were re‐transplanted for a short or long period after the first xeno islet rejection. The recipient monkeys were treated with an immunosuppressive regimen consisting of ATG, humira, and anakinra for induction, and sirolimus and tofacitinib for maintenance therapy. The graft survival days of allo islets in these monkeys were >440, 395, >273, and 127, respectively, similar to that in allo islet transplanted cynomolgus monkeys that received the same immunosuppressive regimen without xeno sensitization. Taken together, it is likely that prior islet xenotransplantation does not affect the survival of subsequent allo islets under clinically applicable immunosuppressants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Islets of Langerhans TransplantationDiabetes MellitusIslets of LangerhansPiperidinesPyrimidinesMaleSwineAnimalsMacaca mulattaTransplantation, HeterologousImmunosuppressive AgentsGraft Survival

Stichwörter der Autor:innen

allo islet transplantationnonhuman primatere-transplantationxeno islet transplantation

Substanzen

tofacitinibImmunosuppressive AgentsPiperidinesPyrimidines

Autor:innen und Institutionen

  • Xenotransplantation Research Center, Seoul National University, College of Medicine, Seoul, South Korea.
  • Department of Microbiology and Immunology, Seoul National University, College of Medicine, Seoul, South Korea.
  • Transplantation Research Institute, Seoul National University Medical Research Center, Seoul National University, College of Medicine, Seoul, South Korea.
  • Cancer Research Institute, Seoul National University, College of Medicine, Seoul, South Korea.
  • Department of Animal Health, Cheongju University College of Health and Medical Sciences, Cheongju, South Korea.
  • Department of Biomedical Sciences, Seoul National University, College of Medicine, Seoul, South Korea.

ORCID-Profile: Jong-Min Kim, Seong-Jun Kang, So-Hee Hong, Hyunwoo Chung, Jun-Seop Shin, Byoung-Hoon Min, Hyun Je Kim, Jongwon Ha, Chung-Gyu Park

Zitieren

APA

Kim, J. M., Kang, S. J., Hong, S. H., Chung, H., Shin, J. S., Min, B. H., Kim, H. J., Ha, J., & Park, C. G. (2024). Long‐term control of diabetes by tofacitinib‐based immunosuppressive regimen after allo islet transplantation in diabetic rhesus monkeys that rejected previously transplanted porcine islets. Xenotransplantation. https://doi.org/10.1111/xen.12850

Vancouver

Kim JM, Kang SJ, Hong SH, Chung H, Shin JS, Min BH, et al. Long‐term control of diabetes by tofacitinib‐based immunosuppressive regimen after allo islet transplantation in diabetic rhesus monkeys that rejected previously transplanted porcine islets. Xenotransplantation. 2024. doi:10.1111/xen.12850

BibTeX
@article{Kim2024,
  author = {Kim, Jong-Min and Kang, Seong-Jun and Hong, So-Hee and Chung, Hyunwoo and Shin, Jun-Seop and Min, Byoung-Hoon and Kim, Hyun Je and Ha, Jongwon and Park, Chung-Gyu},
  title = {Long‐term control of diabetes by tofacitinib‐based immunosuppressive regimen after allo islet transplantation in diabetic rhesus monkeys that rejected previously transplanted porcine islets},
  journal = {Xenotransplantation},
  year = {2024},
  doi = {10.1111/xen.12850}
}
Kostenlos starten →